Vital Medical Center

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)3 trials
• Osteoporosis1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Completed4 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Biogen2 trials
• AstraZeneca1 trial
• Eli Lilly and Company1 trial
• Janssen Research & Development, LLC1 trial
• mAbxience Research S.L.1 trial

Running trials

• Enrolling by invitation

  A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)

  NCT05352919· Phase 3· Biogen· Source

• Active, not recruiting

  Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

  NCT04877691· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)1 recruiting

Closed trials

• Completed

  An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

  NCT05848258· Phase 2· Eli Lilly and Company· Source

• Completed

  A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.

  NCT05338086· Phase 3· mAbxience Research S.L.· Source

• Completed

  A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

  NCT05071664· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

  NCT04961567· Phase 3· Biogen· Source